Major adverse cardiovascular events in patients treated with oral janus kinase inhibitors for atopic dermatitis: a systematic review and meta-analysis

Cecile Ertus,Lucie-Marie Scailteux,Alain Lescoat,Pauline Berthe,Vincent Auffret,Alain Dupuy,Emmanuel Oger,Catherine Droitcourt

ACTA DERMATO-VENEREOLOGICA（2023）

引用 1|浏览2

暂无评分

摘要

Our review highlighted rare cases of MACE among JAK inhibitors users for AD. Janus kinase inhibitors may have little to no effect on the occurrence of MACEs in patients with AD compared to comparators but the evidence is very uncertain. Real-life, long-term, population-level safety studies are needed.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要